The mechanism of the hypergastrinaemia associated with Helicobacterpylori infection is unknown. It may be an effect of the ammonia produced by the bacterium near the antral epithelial surface. We In an attempt to elucidate the mechanism of the hypergastrinaemia associated with H pylori infection, we have examined the effect of inhibiting the bacterium's urease activity and ammonia production on serum gastrin in duodenal ulcer patients.
Abstract
The mechanism of the hypergastrinaemia associated with Helicobacterpylori infection is unknown. It may be an effect of the ammonia produced by the bacterium near the antral epithelial surface. We have examined the effect on serum gastrin of inhibiting H pylon urease activity with acetohydroxamic acid in six duodenal ulcer patients. On day 1 ) the next day (p<003). Further studies performed in one subject confirmed that acetohydroxamic acid lowered the ammonium concentration and raised the urea concentration in gastric juice. The inhibition of urease activity and ammonia production did not result in a fail in the basal gastrin concentration or in the median integrated gastrin response to the peptide meal, which was 78 ng/l.h (range 21-222) on day 1 The next day, the study was repeated in an identical fashion except that the patients received 750 mg acetohydroxamic acid (Lithostat, Mission Pharmacol, USA) with a 50 ml drink of water at 8 am.
Ten days later a third 14C urea breath test was performed to determine whether the temporary inhibition of urease activity had resulted in clearance of the infection.
STUDIES IN PATIENTS WITHOUT H PYLORI INFECTION
Two male patients (aged 25 and 52 years) with a Effectofinhibition ofHelicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects 
Results
The excretion of 14C-CO2 in the breath was considerably lower after the administration of acetohydroxamic acid (Fig 1) . On the first study day, the median 30 minute breath test value was 152% dose/mmol CO2xkg body wtx 100 (range 111-335) compared with a value of 22 (range 14-95) after acetohydroxamic acid (p<003). The median value 10 days after the administration of acetohydroxamic acid was 149 (range which was similar to the pretreatment value (Fig   2) .
In spite of the noticeable suppression of H pylon urease activity, there was no difference between the two study days with respect to the basal or meal stimulated serum gastrin concentrations (Fig 3) . The 
Placebo
Acetohydroxamic acid of juice, collected one hour after the administration of the urease inhibitor, and persisted for the full three and a half hours studied. The ammonium concentrations in gastric juice before the inhibitor were 5-2 and 5-5 mmol/l and values after the inhibitor ranged from 1-9-3-6 mmol/l. The ratio of urea:ammonium in gastric juice before the urease inhibitor was 0-2 whereas after the inhibitor five of the six patients showed values more than I 0. None of the patients experienced any side effects after the administration of acetohydroxamic acid.
Discussion
Acetohydroxamic acid is a specific urease inhibitor that has been used to reduce bacterial ammonia production in patients with renal calculi secondary to chronic urinary tract infection.'0 Reducing the ammonia production lowers the pH of the urine and thereby lessens the tendency for calculi formation. In these patients the drug has been prescribed in a dose of 250 mg four times a day. We administered the drug as a once off dose of 750 mg in order to 210 achieve rapid and effective inhibition of urease activity. tions of urea and ammonium in the gastric juice 7) on of the volunteer also confirmed inhibition of urease activity. We have previously noted that tion, though there is overlap of H pylon negative and were positive subjects with respect to their gastric juice ammomum concentration, the urea ifec-:ammonium ratio in gastric juice provides clear acid separation of the two groups." The median nd a urea:ammonium ratio before the urease inhibitor stric was 0-2, which is within our range for infected nple subjects (0-04-0-7), and that after administration of the inhibitor was 1-2 which is just within our range for patients in whom the infection has been eradicated (I 1-1 13). The finding ofaltered urea and ammonium concentrations in the first sample of juice examined and its persistence throughout the remainder of the three and a half hours observed is consistent with the fact that acetohydroxamic acid is rapidly absorbed from the upper gastrointestinal tract reaching peak plasma concentrations at 60 minutes and has a plasma half life of three and a half to five hours. 12 It is not clear whether the inhibition of H pylori urease activity by oral acetohydroxamic acid is the result of a topical or systemic effect, or both. In spite of the suppression of H pylon urease activity there was no accompanying fall in the basal gastrin concentration or in the gastrin response to the OXO meal. There was also no change in gastrin concentration in the Hpylori negative subjects, which excluded the possibility that a fall in gastrin in those with the infection had been masked by a direct gastrin stimulating effect of the drug.
It has been proposed that the hypergastrmn--~aemia in patients with Hpyloni infection is caused 
